The Ty Louis Campbell Foundation (TLC), a non-profit organization that funds pediatric research, will host its tenth annual gala, a winter wonderland-themed fundraiser to benefit childhood cancer research on Saturday, March 2, 2024, at the Hyatt Regency Greenwich in Old Greenwich from 7:00pm to 12:00 midnight.
Left to right, it’s Beth Raskin, Cindy Campbell (TLC co-founder), and Lynda Gehrman. Photo: Donna Tine
This year’s “Winter Wonderland Gala” will kick off with a cocktail hour followed by a three-course dinner, five-hour open bar, music by NYCE Productions, dancing, live and silent auctions, casino tables, and entertainment.
During the Gala’s cocktail hour, attendees will have the opportunity to bid on raffle items featuring beautiful baskets, gift certificates to local restaurants, and spa/salon packages.
Photo: Donna Tine
The silent auction will include a wide range of priceless experiences such as VIP access to the Macy’s Day Parade, concert tickets, sports outings, memorabilia, getaways and much more.
In addition to the evening’s festivities, the Gala will include a special “Heart of Gold” award presentation to a deserving honoree for their exemplary efforts in supporting pediatric cancer research.
“Our annual gala is TLC’s largest adult-centered fundraising event of the year with 100% of the proceeds going directly to funding new research treatments for children who are currently battling aggressive cancers,” said Cindy Campbell, co-founder of the Ty Louis Campbell Foundation. “Donating an auction item, becoming a Gala sponsor or purchasing a ticket will greatly impact TLC in its ability to fund urgently needed therapies and treatment options for children who desperately need them now.”
In keeping with the Gala’s festive winter wonderland theme, attendees are encouraged but not required to wear themed attire; however, cocktail attire is required.
For more information on ticket and sponsorship opportunities, please visit www.TLCGala.org or call 845-200-7486.
The Ty Louis Campbell Foundation is a nonprofit organization that funds innovative research and clinical trials specifically geared toward the treatment of the most aggressive childhood cancers. Its mission is to help fund the intelligence and technology that will improve long-term survival rates and minimize side-effects for children diagnosed with the deadliest cancers, while helping to care for families when their child is in treatment by providing financial assistance and uplifting experiences.